Kang, Y., Li, C., & Mei, H. (2024). Off-the-shelf CAR-T cell therapies for relapsed or refractory B-cell malignancies. Journal of Hematology & Oncology, 17(1), 1. https://doi.org/10.1186/s13045-024-01550-9
Chicago-referens (17:e uppl.)Kang, Yun, Chenggong Li, och Heng Mei. "Off-the-shelf CAR-T Cell Therapies for Relapsed or Refractory B-cell Malignancies." Journal of Hematology & Oncology 17, no. 1 (2024): 1. https://doi.org/10.1186/s13045-024-01550-9.
MLA-referens (9:e uppl.)Kang, Yun, et al. "Off-the-shelf CAR-T Cell Therapies for Relapsed or Refractory B-cell Malignancies." Journal of Hematology & Oncology, vol. 17, no. 1, 2024, p. 1, https://doi.org/10.1186/s13045-024-01550-9.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
